Physician profile
Robert C Kerschen
NPI 1821014432
$19,614.80
in general payments reported to CMS, 2019-2025
10 companies · $8,448 in 2025
The $8,448 reported for 2025 was more than what 99% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,358 · 2020: $212 · 2021: $355 · 2022: $2,453 · 2023: $256 · 2024: $2,532 · 2025: $8,448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $8,409 · Travel and Lodging: $2,046 · Food and Beverage: $702 · Entertainment: $79.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $8,408.53 |
| Travel and Lodging | $2,046.49 |
| Food and Beverage | $701.63 |
| Entertainment | $79.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| A-Dec, INC. | $14,636.79 | 2019-2025 | |
| Dentsply Sirona INC | $2,062.37 | 2019-2024 | Suresmile |
| Henry Schein, INC. | $1,054.86 | 2019-2025 | |
| Sirona Dental Systems Gmbh | $1,000.00 | 2022 | |
| Ultradent Products INC | $459.17 | 2022-2023 | Opalescence |
| Ivoclar Vivadent, INC. | $183.16 | 2024 | |
| Straumann USA LLC | $119.65 | 2019-2022 | |
| Nobel Biocare USA | $58.75 | 2020-2021 | |
| Voco America INC. | $23.58 | 2020 | |
| 3m Company | $16.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kerschen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.